Plato Investment Management LTD Entrada Therapeutics, Inc. Transaction History
Plato Investment Management LTD
- $1.07 Trillion
- Q2 2024
A detailed history of Plato Investment Management LTD transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 61 shares of TRDA stock, worth $1,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 1,116
94.53%
Holding current value
$1,008
Previous $15.8 Million
94.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
85Shares Held
27.7MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$80.5 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$73.2 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$72.9 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$51.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$28 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $519M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...